Global /Taiwan /Healthcare /Medical Devices /4131

NeoCore Technology Co., Ltd.

4131

• TPEX: 4131 • Delayed

35.10TWD -0.6%

1.11 USD

As of 9 June 2026, NeoCore Technology Co., Ltd. has a market cap of $44.48M USD, ranking #31403 globally and #1891 in Taiwan. It ranks #2841 in the Healthcare sector, and #587 in the Medical Devices industry.

Global Rank

31403

Country Rank

1891

Sector Rank

2841

Industry Rank

587

Key Stats

Market Cap

$44.48MUSD

1.4B TWD

Enterprise Value

$46.44MUSD

1.47B TWD

Revenue (TTM)

$7.75MUSD

244.66M TWD

EBITDA (TTM)

-$1.37MUSD

-43.14M TWD

Net Income (TTM)

-$977.59KUSD

-30.87M TWD

EBITDA Margin

-18%

Profit Margin

-13%

PS Ratio

5.7

PB Ratio

4.7

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Devices

CEO

Wen-Sheng Ji open_in_new

Employees

Founded

1987

Website

neocore.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.6%	4.4%	-1.1%	-10%	13%	-16%	1%	26%	86%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	4131 浩泰精準股份有限公司 ISIN: TW0004131008 Shares Out.: Shares Outstanding: 39.79M¹ Shares Float: 30.459M² TV: TradingView: TPEX: 4131 SA: Stock Analysis: TPEX: 4131 YF: Yahoo Finance: 4131.TWO GF: Google Finance: TPEX: 4131 BA: Barron's: 4131 MS: Morningstar: ROCO: 4131	35.10 TWD	TV: TradingView: TPEX: 4131 SA: Stock Analysis: TPEX: 4131 YF: Yahoo Finance: 4131.TWO GF: Google Finance: TPEX: 4131 BA: Barron's: 4131 MS: Morningstar: ROCO: 4131

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan City, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Sunmax Biotechnology Co., Ltd. TPEX: 4728	$668.33M 21.1B TWD 1K%	29.1	Taiwan
TaiDoc Technology Corp. TWSE: 4736	$377.54M 11.92B TWD 749%	8.3	Taiwan
YD Bio Ltd. NASDAQ: YDES	$364.92M 720%	-	Taiwan
United Orthopedic Corp. TPEX: 4129	$302.34M 9.55B TWD 580%	17.5	Taiwan
Bioteque Corp. TPEX: 4107	$254.57M 8.04B TWD 472%	15.0	Taiwan
Hi-Clearance Inc. TPEX: 1788	$191.04M 6.03B TWD 329%	16.4	Taiwan

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 389K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 361K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 358K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 284K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 271K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 229K%	22.2	Ireland

chevron_leftBack